CARE Ratings Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

Price Movement and Market Context

On 12 Feb 2026, CARE Ratings Ltd closed at ₹1,580.00, down from the previous close of ₹1,613.85, marking a 2.10% decline on the day. The stock’s intraday range was relatively narrow, with a low of ₹1,580.00 and a high of ₹1,613.90. This price action comes against the backdrop of a 52-week high of ₹1,964.80 and a 52-week low of ₹1,057.65, indicating that the stock remains closer to its upper range but has retraced from recent highs.

Comparatively, CARE Ratings’ recent returns have lagged the broader Sensex index over short-term periods. The stock posted a 1-week return of -2.04% versus the Sensex’s 0.50%, and a 1-month return of -2.55% against the Sensex’s 0.79%. Year-to-date, the stock is down 1.30%, slightly worse than the Sensex’s -1.16%. However, over longer horizons, CARE Ratings has outperformed significantly, delivering a 26.00% return over one year compared to the Sensex’s 10.41%, and an impressive 226.21% over five years versus the Sensex’s 63.46%. This long-term outperformance underscores the company’s resilience despite recent technical headwinds.

Technical Indicators: A Mixed Bag

The technical landscape for CARE Ratings is nuanced. The daily moving averages have turned bearish, signalling short-term downward pressure on the stock. This aligns with the recent price decline and suggests caution for traders relying on daily trends.

On the weekly timeframe, the Moving Average Convergence Divergence (MACD) indicator remains bullish, indicating underlying momentum that could support a rebound or consolidation. The weekly Know Sure Thing (KST) oscillator also supports this bullish stance, suggesting that momentum is still positive in the medium term. However, the weekly On-Balance Volume (OBV) is mildly bearish, hinting at some selling pressure despite the momentum indicators.

Conversely, monthly indicators paint a more cautious picture. The MACD is mildly bearish, and the Relative Strength Index (RSI) on the monthly chart is signalling bearish momentum, reflecting weakening strength over a longer horizon. The Bollinger Bands on the monthly timeframe are mildly bullish, indicating that volatility remains contained and the stock may be poised for a potential stabilisation or gradual recovery. The monthly KST is mildly bearish, reinforcing the need for vigilance among investors.

Dow Theory assessments on both weekly and monthly charts show no clear trend, suggesting that the stock is in a consolidation phase without a definitive directional bias. This lack of trend confirmation adds complexity to the technical outlook.

Mojo Score and Analyst Ratings

CARE Ratings currently holds a Mojo Score of 54.0, placing it in the 'Hold' category. This represents an upgrade from its previous 'Sell' rating as of 10 Feb 2026, reflecting improved technical and fundamental assessments. The Market Cap Grade stands at 3, indicating a mid-tier market capitalisation relative to peers in the capital markets sector.

The upgrade in rating is consistent with the mixed technical signals observed. While short-term momentum has weakened, the medium-term indicators and long-term price appreciation support a cautious but constructive outlook. Investors should weigh these factors carefully, balancing the potential for near-term volatility against the stock’s demonstrated resilience over multiple years.

Sector and Industry Context

Operating within the capital markets sector, CARE Ratings faces sector-specific headwinds and opportunities. The capital markets industry has experienced bouts of volatility amid macroeconomic uncertainties and regulatory developments. CARE Ratings’ technical profile reflects this environment, with oscillating momentum indicators and a sideways to mildly bearish trend shift.

Relative to the broader sector, CARE Ratings’ long-term returns remain robust, suggesting that the company has successfully navigated cyclical challenges. However, the recent technical deterioration signals that investors should monitor sector developments closely, as further volatility could impact the stock’s trajectory.

Technical Momentum and Trading Implications

The shift from a sideways to a mildly bearish technical trend suggests that traders should exercise caution in the near term. The bearish daily moving averages and monthly RSI indicate potential for further downside or consolidation before a sustained recovery. However, the weekly MACD and KST oscillators’ bullish readings imply that any pullback may be limited or temporary.

For momentum traders, the current environment calls for close attention to support levels near ₹1,580 and resistance around the recent highs near ₹1,614. A decisive break below support could confirm a deeper correction, while a rebound above resistance might signal renewed buying interest.

Long-term investors may find comfort in the stock’s strong multi-year returns and upgraded Mojo Grade, but should remain vigilant to technical developments and sector dynamics that could influence performance.

Conclusion: Balanced Outlook Amid Technical Divergence

CARE Ratings Ltd’s recent technical parameter changes highlight a nuanced momentum shift. While daily and monthly indicators suggest caution with bearish tendencies, weekly signals provide a counterbalance of bullish momentum. The stock’s strong long-term returns and upgraded Mojo Grade support a measured 'Hold' stance, reflecting neither a strong buy nor a sell recommendation at this juncture.

Investors should monitor key technical levels and sector developments closely, as the stock navigates this transitional phase. Those with a medium to long-term horizon may view current weakness as a potential entry point, while short-term traders should remain alert to volatility and confirmatory signals before committing.

Overall, CARE Ratings remains a stock with solid fundamentals and a complex technical profile, warranting careful analysis and disciplined risk management.

Unlock special upgrade rates for a limited period. Start Saving Now →